BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11699327)

  • 1. Isokinetic muscle performance in major depressive disorder: alterations by antidepressant therapy.
    Bilici M; Koroglu MA; Cakirbay H; Guler M; Tosun M; Aydin T; Tan U
    Int J Neurosci; 2001 Aug; 109(3-4):149-64. PubMed ID: 11699327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isokinetic muscle performance in major depressive disorder: alterations by antidepressant therapy.
    Bilici M; Cakirbay H; Koroglu MA; Guler M; Tosun M; Aydin T; Tan U
    Int J Neurosci; 2001 Sep; 110(1-2):9-23. PubMed ID: 11697214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 Correlates with Severity of Depression in Patients with Major Depressive Disorder and Is Ameliorated after Antidepressant Treatment.
    Hung YY; Wu MK; Tsai MC; Huang YL; Kang HY
    Cells; 2019 Jun; 8(7):. PubMed ID: 31252530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
    Hung YY; Lin CC; Kang HY; Huang TL
    Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low cocaine- and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients.
    Yoon HS; Hattori K; Sasayama D; Kunugi H
    J Affect Disord; 2018 May; 232():134-138. PubMed ID: 29486339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder.
    Hung YY; Huang KW; Kang HY; Huang GY; Huang TL
    Psychopharmacology (Berl); 2016 May; 233(9):1707-14. PubMed ID: 26415953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
    Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
    Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
    Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
    Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with antidepressant use in depressed and non-depressed community-dwelling elderly: the three-city study.
    Soudry A; Dufouil C; Ritchie K; Dartigues JF; Tzourio C; Alpérovitch A
    Int J Geriatr Psychiatry; 2008 Mar; 23(3):324-30. PubMed ID: 17907265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ghrelin levels and the effects of antidepressants in major depressive disorder and panic disorder.
    Ishitobi Y; Kohno K; Kanehisa M; Inoue A; Imanaga J; Maruyama Y; Ninomiya T; Higuma H; Okamoto S; Tanaka Y; Tsuru J; Hanada H; Isogawa K; Akiyoshi J
    Neuropsychobiology; 2012; 66(3):185-92. PubMed ID: 22948519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants.
    Morita T; Senzaki K; Ishihara R; Umeda K; Iwata N; Nagai T; Hida H; Nabeshima T; Yukawa K; Ozaki N; Noda Y
    Hum Psychopharmacol; 2014 May; 29(3):280-6. PubMed ID: 24911578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects.
    Pae CU; Mandelli L; Kim TS; Han C; Masand PS; Marks DM; Patkar AA; Steffens DC; De Ronchi D; Serretti A
    Biomed Pharmacother; 2009 Mar; 63(3):228-35. PubMed ID: 18502089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antidepressant treatment on total antioxidant capacity and free radical levels in patients with major depressive disorder.
    Chang CC; Lee CT; Lan TH; Ju PC; Hsieh YH; Lai TJ
    Psychiatry Res; 2015 Dec; 230(2):575-80. PubMed ID: 26476591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls.
    Kurita H; Maeshima H; Kida S; Matsuzaka H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H
    J Affect Disord; 2013 Apr; 146(2):205-12. PubMed ID: 23102506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments.
    Bilici M; Efe H; Köroğlu MA; Uydu HA; Bekaroğlu M; Değer O
    J Affect Disord; 2001 Apr; 64(1):43-51. PubMed ID: 11292519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy.
    Grosse L; Carvalho LA; Birkenhager TK; Hoogendijk WJ; Kushner SA; Drexhage HA; Bergink V
    Psychopharmacology (Berl); 2016 May; 233(9):1679-88. PubMed ID: 25953327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment.
    Gaspersz R; Lamers F; Kent JM; Beekman ATF; Smit JH; van Hemert AM; Schoevers RA; Penninx BWJH
    J Psychiatr Res; 2017 Jan; 84():41-48. PubMed ID: 27693981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroretinographic assessment in major depressed patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background?
    Fornaro M; Bandini F; Ogliastro C; Cordano C; Martino M; Cestari L; Escelsior A; Rocchi G; Colicchio S; Perugi G
    J Affect Disord; 2011 Dec; 135(1-3):154-9. PubMed ID: 21820182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No changes in striatal dopamine transporter in antidepressant-treated patients with major depression.
    Wu CK; Chin Chen K; See Chen P; Chiu NT; Yeh TL; Lee IH; Yang YK
    Int Clin Psychopharmacol; 2013 May; 28(3):141-4. PubMed ID: 23524636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced serum VGF levels were reversed by antidepressant treatment in depressed patients.
    Jiang H; Chen S; Lu N; Yue Y; Yin Y; Zhang Y; Jiang W; Liang J; Yuan Y
    World J Biol Psychiatry; 2017 Dec; 18(8):586-591. PubMed ID: 28635540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.